Sat, Dec 27, 2014, 3:21 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

gizmo_puppy95 208 posts  |  Last Activity: Dec 23, 2014 9:12 PM Member since: Feb 24, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • gizmo_puppy95 gizmo_puppy95 Dec 23, 2014 9:12 PM Flag

    Answer: 21,316,577
    Public Offering after fees: $7.2 Million
    Price was: 4.45
    Fees to Wainwright and Roth.
    Other shares that could be O/S as in Warrants, Options and other: Around 8 to 9 Million Additional shares.
    Actual Market Cap as of December 23, 2014: $78.6 Million.
    Yahoo's Market Cap is "Misrepresentative"

  • gizmo_puppy95 gizmo_puppy95 Dec 23, 2014 8:28 PM Flag

    How many Shares was the Public offering?
    How many outstanding shares does this company REALLY have now?
    Do you know the Actual Market Cap...after the issuance?
    Now how much cash on hand do they have?
    It seems a lot of pumpers but not too many know what's going on.

  • Reply to

    Cramer Feeling some Pressure

    by gizmo_puppy95 Dec 22, 2014 11:14 PM
    gizmo_puppy95 gizmo_puppy95 Dec 23, 2014 3:57 PM Flag

    My earlier reply must not of posted.
    AF is figuring me on Twitter also as I play with this idiot. He has now quit replying to my tweets.
    He knows he has just about the worst most unprofessional over paid, unethical boss around...yet he wouldn't dare to say anything as he would lose his easy bashing blog and his hedgie buds.
    AF is a JOKE and so is The Street is.

  • Reply to

    The 54%, is it so bad?

    by bi0technician Dec 22, 2014 9:58 PM
    gizmo_puppy95 gizmo_puppy95 Dec 23, 2014 2:23 PM Flag

    Gawd...their are a lot of Idiots on this board.
    Bottom line is that we won't know until 9 months and six months should be a good indication. 3 months should of been an indication.

  • gizmo_puppy95 gizmo_puppy95 Dec 23, 2014 10:15 AM Flag

    $9 Million?
    Wow and they already paid how much for it in bonuses for NDA, approval and next milestones before they can effectively use any of it.
    It's a disaster unless they can get it over $30 million until patent expires.

  • gizmo_puppy95 by gizmo_puppy95 Dec 23, 2014 10:12 AM Flag

    Patent to expire in 2015 and Galena states that they will not be able to expand, extend or reapply for this patent. It would be reassuring if they had this patent until 2025 or so.

  • gizmo_puppy95 by gizmo_puppy95 Dec 22, 2014 11:14 PM Flag

    Large shareholder of the Street is calling him out to either sell the company or quite CNBC. The Street has been a total failure it has lost over 90% of its value since opening and Cramer pays himself $3.5 Million a year. I think AF should of put his boss in that poll of "worst CEO's for 2014".
    Cramer is Worse than Kriegsman.
    AF is so LUCKY to have a job where he can be blogger and manipulate companies.

  • gizmo_puppy95 by gizmo_puppy95 Dec 22, 2014 3:33 PM Flag

    You didn't help yourselves and simultaneously you didn't help fact you are going to HURT patients. Can't believe this deal...are they Stupid?
    Study this deal people...for pharma investors as a whole this is not a good deal.

  • gizmo_puppy95 by gizmo_puppy95 Dec 22, 2014 1:50 PM Flag

    How much Cash on hand this company has and how long it is expected to last?

  • Reply to

    The problem with the open letter

    by lottawatta2013 Dec 22, 2014 9:27 AM
    gizmo_puppy95 gizmo_puppy95 Dec 22, 2014 12:11 PM Flag

    That was a containment much for the bounce.

  • Reply to


    by y0da7119 Dec 22, 2014 8:56 AM
    gizmo_puppy95 gizmo_puppy95 Dec 22, 2014 10:55 AM Flag

    Is this Fanelli or an impostor?

  • Reply to

    Positive Results - SYN004!

    by tina_bridgett50 Dec 22, 2014 9:01 AM
    gizmo_puppy95 gizmo_puppy95 Dec 22, 2014 10:53 AM Flag

    Call me a cheap date...I'm fine with that. LOL

  • Reply to

    unique company

    by roymelkids Dec 18, 2014 3:45 PM
    gizmo_puppy95 gizmo_puppy95 Dec 21, 2014 5:26 PM Flag

    "Well Prepared" Clinical Trials...Please show me the proof to well prepared. This management team has not been well prepared for years, but if you know they are "well prepared" I would like you to explain in detail.

  • Reply to


    by helpme_hanna Dec 21, 2014 2:13 PM
    gizmo_puppy95 gizmo_puppy95 Dec 21, 2014 2:51 PM Flag

    Most of us are here just because of RX-109 potentials. If the scarring trials fail, RXII will stay below $5 for several years---probably under $3. Why? That would ruin confidence of investors for other conditions and capturing 10% of the market with Samcyprone-- that will take years--6-8 years from now. Even Multi-Blockbuster Drugs take a good year or two Post Approval to make good money. Usually year 3 post approval is the year that sales escalate.
    Tough road ahead from here...but I am expecting a bounce on Monday, possibly back towards $1.95 to $2.00. 50/50 chance as the candle from Friday is not very Monday will be the day that indicates if this stock goes back toward the $2 range or continues to drift below the BB. This will kind of be in a stalemate until RXI-109 is able to validate to the common eye; could be 9 August or September---expect a run. Possible a Six Month Run also...IF they display pictures, but if they don't say anything at six months-- that will NOT be a good sign. We really should see benefits at six months which would be late May or June, but definitely by 9 months.

  • Reply to

    RXI Pharmaceuticals

    by guitaristry Dec 21, 2014 1:17 AM
    gizmo_puppy95 gizmo_puppy95 Dec 21, 2014 2:37 PM Flag

    Take a look at what happened to Polymedix PYMX -- they had great technology with some excellent scientists, but a couple bad decisions and they went completely bankrupt and lost it ALL. This happened in ONE year and they lost $500 Million in MC in one year. CTIX bought all their assets in bankruptcy for $5 Million. Since then CTIX market cap has increased by $360 Million.
    It's ALL about the decisions that are made.

  • Reply to

    Need some questions addressed by Dr. C.

    by tene1961 Dec 20, 2014 3:26 PM
    gizmo_puppy95 gizmo_puppy95 Dec 20, 2014 7:32 PM Flag

    $10 Million doesn't go far, so just when the stock begins to run...Expect more dilution.
    Unfortunately...this is the position that RXII is in right now and the foreseeable future.
    That doesn't mean that the stock won't double or triple...because If you consider the market cap of around $40--$90 million pending on how many new shares will be introduced to the float in the next six months -- it may still be perceived as a low market cap. I just see a tough road ahead in the near term.
    It will be a learning experience for me to observe what occurs here... prepare myself for when another small pharma takes a similar road.
    I think Geert is doing the best he can and he is a good guy....Much Better than CYTR's CEO Kriegsman -- where this was spun off from.
    He has definitely made some mistakes...I wonder if a larger Pharma would be willing to take a risk and buy this out right now?
    Wonder how much?
    Alright Good Luck Everyone.

  • Reply to

    Need some questions addressed by Dr. C.

    by tene1961 Dec 20, 2014 3:26 PM
    gizmo_puppy95 gizmo_puppy95 Dec 20, 2014 7:24 PM Flag

    I would rather get this over right is a dark cloud of insecurity hanging over which could significantly lower the stock price.
    This stock is 27% owned by Non-Retail? How will they perceive this and what will they do?
    What will the Non-Retailers do?
    The sector of Small Biotech's are beginning to start their annual run --- RXII is going the opposite. Will people hold on here or will they sell and ride the band wagon to procure profits?
    LPC will begin buying immediately as RXII needs money right now this second, and these are NEW shares introduced to the float...Dilution.
    Hapten Pharmaceuticals will receive shares --- More Dilution.
    There are a lot of uncertainties.
    This is like a shot from half court with one second left ... the shot looks good... it is rolling around the is ____ Wait ... this second is going to take a minimum of Six months....Standby.

  • Reply to

    Need some questions addressed by Dr. C.

    by tene1961 Dec 20, 2014 3:26 PM
    gizmo_puppy95 gizmo_puppy95 Dec 20, 2014 7:09 PM Flag

    Actually I may have been a bit hard on Geert as I believe he is trying very hard to establish rapport with shareholders. The problem is TIME and money.
    The Phase II -b trial will not be until 2016...over one year from now and that is if everything goes as planned. Unless this is a Misprint and meant to say 2015???
    The Short Term Prognosis for RXII: Not too good
    Medium Term: 9-12 months: All depends on 9 month results of RX-109
    Long Term:Depends on deals, partnerships and dilution...Unknown.
    I think that Geert is doing this as a back up plan in case RX-109 fails and he will have something that will be in a phase II so the company will not go into bankruptcy.
    Here is what Geert says: There will be dilution but this should be offset by the addition of Samcyprone.
    An Earlier deal with LPC was a disaster in which they left $18 Million on the table. RXI needs money NOW, so I expect them to IMMEDIATELY have LPC start buying shares which will raise O/S.
    Also: There are an Undisclosed amount of shares going to Hapten many, we don't know.
    This is almost like taking a final shot from half court with one second remaining to win the game...the shot looks good... the ball is rolling on the rim... and rolling - but this second will take a minimum of six months...question is-- will it go in?
    So for the short term this may suffer. It will be a learning experience for me to monitor such a situation so I can be prepared when it occurs in the future with another company.
    About 27% of this company is owned by Non-Retail and the question will they respond?
    As I mentioned: I believe Lincoln Park will be buying immediately, but these will be Newly issued shares. LPC will want them cheap, so I bet they hedge it and try to keep this as low as possible until they are invested. This could actually be in about one year IF RXI wants to. RXI really left unused money on the table last time.
    Then you have shares to be converted...contin

  • Reply to

    Swung to a profit today

    by jrdelane Dec 19, 2014 3:28 PM
    gizmo_puppy95 gizmo_puppy95 Dec 20, 2014 5:42 PM Flag

    I agree. That is virtually my own assessment.

  • Reply to

    A word or two on dilution

    by helpme_hanna Dec 20, 2014 9:49 AM
    gizmo_puppy95 gizmo_puppy95 Dec 20, 2014 2:28 PM Flag

    This needs to be Clarified...I don't see them abandoning RX-109 just yet, but after 2015 if nothing has changed? IDK
    I am a bit confounded about the Direction or multiple directions they are going, the costs associated, the potential convertible shares, the 100,000 FREE shares given to RXII and just how much dilution took place over acquiring DCP. I would also like to know the precise royalties and projected costs of progressing this to an approval and time frame....yeah, that was a lot.
    I hope an HONEST press release is issued to clarify.
    I do believe that the sell off was to help LPC so they can buy cheap shares when RXII informs them to buy and also confusion about the 3 PR's -- 3 month at 54%, new financing and license acquisition.

0.67-0.0100(-1.47%)Dec 26 4:01 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
Tesla Motors, Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST